TY - JOUR
T1 - Low glucose-1, 6-bisphosphate and high fructose-2, 6-bisphosphate concentrations in muscles of patients with glycogenosis types VII and V
AU - Yamada, Yuya
AU - Kono, Norio
AU - Nakajima, Hiromu
AU - Shimizu, Takao
AU - Kiyokawa, Hiraoki
AU - Kawachi, Masanori
AU - Ono, Akira
AU - Nishimura, Takamichi
AU - Kuwajima, Masamichi
AU - Tarui, Seiichiro
N1 - Funding Information:
The authors wish to thank Drs. Tomoyuki Yamasaki, Tomoya Hamaguchi, Kikuko Hotta and Ikuo Mineo for discussion. This work was supported, in part, by Grants-in-Aid for Scientific Research and for Scientific Research on Priority Areas from the Ministry of Education, Science and Culture of Japan; and a grant from the Gout Research Foundation of Japan.
PY - 1991/4/15
Y1 - 1991/4/15
N2 - The level of glucose-1, 6-bisphosphate, a potent allosteric activator of phosphofructokinase, was markedly decreased in muscles of patients with glycogenosis type VII (muscle phosphofructokinase deficiency) and type V (muscle phosphorylase deficiency). Glucose-1-phosphate kinase activity in muscle was virtually absent in a patient with glycogenosis type VII, whereas it was normal in a patient with type V blycogenosis. Glucose-1-phosphate level was increased in type VII glycogenosis, whereas it was decreased in type V glycogenosis. Another activator of phosphofructokinase, fructose-2, 6-bisphosphate was increased in muscles of patients with both types of glycogenosis although it was much higher in type VII than in type V. This finding may be partly related to the difference of fructose-6-phosphate concentrations. The results suggest that phosphofructokinase would contribute to the major glucose-1-phosphate kinase activity in normal human muscle and would also form a kind of self-activating system.
AB - The level of glucose-1, 6-bisphosphate, a potent allosteric activator of phosphofructokinase, was markedly decreased in muscles of patients with glycogenosis type VII (muscle phosphofructokinase deficiency) and type V (muscle phosphorylase deficiency). Glucose-1-phosphate kinase activity in muscle was virtually absent in a patient with glycogenosis type VII, whereas it was normal in a patient with type V blycogenosis. Glucose-1-phosphate level was increased in type VII glycogenosis, whereas it was decreased in type V glycogenosis. Another activator of phosphofructokinase, fructose-2, 6-bisphosphate was increased in muscles of patients with both types of glycogenosis although it was much higher in type VII than in type V. This finding may be partly related to the difference of fructose-6-phosphate concentrations. The results suggest that phosphofructokinase would contribute to the major glucose-1-phosphate kinase activity in normal human muscle and would also form a kind of self-activating system.
UR - http://www.scopus.com/inward/record.url?scp=0025814891&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0025814891&partnerID=8YFLogxK
U2 - 10.1016/0006-291X(91)90881-7
DO - 10.1016/0006-291X(91)90881-7
M3 - Article
C2 - 2018547
AN - SCOPUS:0025814891
SN - 0006-291X
VL - 176
SP - 7
EP - 10
JO - Biochemical and Biophysical Research Communications
JF - Biochemical and Biophysical Research Communications
IS - 1
ER -